1990
DOI: 10.1128/jb.172.12.6942-6949.1990
|View full text |Cite
|
Sign up to set email alerts
|

Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones

Abstract: The norA gene cloned from chromosomal DNA of quinolone-resistant Staphylococcus aureus TK2566 conferred relatively high resistance to hydrophilic quinolones such as norfloxacin, enoxacin, ofloxacin, and ciprofloxacin, but only low or no resistance at all to hydrophobic ones such as nalidixic acid, oxolinic acid, and sparfloxacin in S. aureus and Escherichia coli. The The increase in methicillin-resistant Staphylococcus aureus is a serious problem because only a few effective agents are clinically available. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

15
310
0

Year Published

1991
1991
2011
2011

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 432 publications
(327 citation statements)
references
References 39 publications
15
310
0
Order By: Relevance
“…These mechanisms include export of the metabolite out of the producing cell. The phlE gene, located at the 39 end of the phlACBD operon in P. fluorescens strains (Bangera & Thomashow, 1996Delany, 1999) encodes a putative transmembrane permease with 12 predicted transmembrane segments (TMS) (Bangera & Thomashow, 1999 transporter mediating resistance to a range of structurally dissimilar drugs (Paulsen & Sukurray, 1993;Yoshida et al, 1990). PhlE also has structural similarity with integral membrane proteins associated with resistance which are encoded within clusters responsible for polyketide biosynthesis (Brautaset et al, 2000; Fernandez-Moreno et al, 1991;Guillfoile & Hutchinson, 1992;Marger & Saier, 1993;Molnar et al, 2000).…”
Section: Introductionmentioning
confidence: 99%
“…These mechanisms include export of the metabolite out of the producing cell. The phlE gene, located at the 39 end of the phlACBD operon in P. fluorescens strains (Bangera & Thomashow, 1996Delany, 1999) encodes a putative transmembrane permease with 12 predicted transmembrane segments (TMS) (Bangera & Thomashow, 1999 transporter mediating resistance to a range of structurally dissimilar drugs (Paulsen & Sukurray, 1993;Yoshida et al, 1990). PhlE also has structural similarity with integral membrane proteins associated with resistance which are encoded within clusters responsible for polyketide biosynthesis (Brautaset et al, 2000; Fernandez-Moreno et al, 1991;Guillfoile & Hutchinson, 1992;Marger & Saier, 1993;Molnar et al, 2000).…”
Section: Introductionmentioning
confidence: 99%
“…In Gram-negative bacteria, tetracycline resistance is mostly assigned to the drug etitux systems, which are classified into A-H [11]. They have a conserved sequence motif, G(K/R)XSD(R/K)XGR(R/K), in the first cytoplasmic loop (named loop2-3), which is common not only in bacterial drug export proteins [12,13] but also in the secondary transporters and belongs to a major facilitator family [14,15]. Tet(K) and Tet(L) also contain a derivative of this motif, GKXSDXX(X/G)XK(K/R), in the corresponding loop, indicating that they belong to a major facilitator family.…”
Section: Introductionmentioning
confidence: 99%
“…For example, human P-glycoprotein, the product of the MDR1 gene, is highly homologous to the protein MDR2, which does not efflux drugs but is a specific phosphatidylcholine flippase (6). Similarly, the bacterial multidrug transporters Bmr and Blt of Bacillus subtilis and NorA of Staphylococcus aureus are highly homologous to the efflux transporters whose only known substrate is tetracycline (7)(8)(9)(10).…”
mentioning
confidence: 99%